Biomedical Diagnostics (BMD) strengthens its sales force by recruiting Hugues Le Choismier as International Sales Director
"After the successful closure of a round of equity financing with Truffle Capital and AGF Private Equity in November 2009, BMD is continuing to sharpen its organizational structure by recruiting Hugues Le Choismier, an international expert in sales and marketing in the pharmaceutical and diagnostics industries", commented Denis Fortier, BMD's Assistant CEO.
Hugues Le Choismier has 27 years of experience in the pharmaceutical and diagnostics industries in the complementary fields of sales, marketing, corporate communication and general management. Since 2006, he has held a number of high-responsibility positions at Siemens: first as Head of Sales (Dec. 2006 - March 2007), then as Head of Sales at Siemens Medical Solutions Diagnostics (March 2007 - Sept. 2008) and, lastly, as Director of Sales, Marketing and Communication, Siemens Medical Solutions Diagnostics (Oct. 2008 - present). Hugues started his career with Bayer and was successively appointed as Sales Director, Bayer Pharma (Jan. 1996 - March 2001), Marketing Director, Bayer Pharma (March 2001 - Dec. 2002) and Sales Director, Bayer Diagnostics (March - Nov. 2006). He acquired solid international experience as CEO of Bayer Pharma's regional subsidiary in Morocco (Oct. 2003 to March 2006) and then as Manager, Nordic and Baltic Countries, at Bayer's global headquarters in Leverkusen, Germany.
Hugues Le Choismier has a degree in Management Control and graduated as a Lieutenant from Draguignan Military Academy.
Other news from the department people
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.